This content is machine translated Post-pancreatitis diabetes Insulin requirement three times as high as for type 2 Post-pancreatitis diabetes mellitus ( PPDM) is a common consequence of chronic pancreatitis (CP). However, patients with PPDM are often misclassified as type 2 diabetics. However, clinically significant complications may be…
View Post 5 min This content is machine translated Implement KDIGO guidelines CKD in type 2 diabetes – from screening to patient-centered care Treatment options for patients with diabetes and chronic kidney disease (CKD) have improved significantly thanks to new therapeutic options from the SGLT-2-i, GLP-1-RA and MRA drug classes. The new guidelines…
View Post 3 min This content is machine translated PANCREATIC CELLS Exploration map Neurogenin 3 (NEUROG3), the mutation of which can lead to diabetes, is only active for a short time during pancreatic development, which is why its behavior and dynamics, particularly in…
View Post 2 min This content is machine translated DIABETES AND OBESITY Influence of movement and muscle regulation Researchers from Helmholtz Munich and DIfE have taken a closer look at the cellular basis and signaling pathways that are crucial for the positive impact of physical activity on our…
View Post 10 min This content is machine translated Thyroid Diseases Clarification of thyroid nodules With the increasing use of imaging techniques, the incidence of incidentally detected thyroid nodules in particular has risen sharply in recent years. In addition, the thyroid gland as an important… CME-Test
View Post 5 min This content is machine translated Chronic renal failure New therapy standard on the rise Several innovative therapeutic options are expanding the options for treating patients with chronic kidney disease ( CKD). SGLT-2 inhibitors (SGLT-2-i) can now be considered an established treatment option – even…
View Post 5 min This content is machine translated Diabetes Technologies AID systems are indispensable in type 1 diabetes Modern innovative technologies can significantly reduce the diabetes-related burden. Daily insulin administration is vital for type 1 diabetics. The ideal therapy would be glucose-dependent control of insulin delivery without any…
View Post 7 min This content is machine translated SCORE2 diabetes 10-year estimate of cardiovascular risk in type 2 diabetes. To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease in individuals aged over 40 years with type 2 diabetes in four different…
View Post 5 min This content is machine translated Obesity GLP-1 analogs and dual incretin agonists to support weight loss. Pathological obesity is a key risk factor for the development of life-threatening secondary complications. Until recently, bariatric surgery was the only effective method for obesity sufferers to achieve a sustained…
View Post 5 min This content is machine translated Heart failure in type 2 diabetes Success story of SGLT-2 inhibitors – impressive evidence base. The SGLT(“sodium glucose-linked transporter”)-2 inhibitors have demonstrated cardioprotective effects in addition to antidiabetic effects. The current evidence supports the benefit of several agents of SGLT-2-i in the treatment of heart…
View Post 3 min This content is machine translated GLP-1-RA and dual GLP-1/GIP agonists. Tackling obesity – not only diabetics benefit from the effects While glucagon-like peptide (GLP)-1 receptor agonists have been successfully used in the treatment of diabetes for some time, there are now agents that activate not only the GLP-1 receptor but…
